Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Wiener Medizinische Wochenschrift (1946)
|
January 1, 1994
[Secondary disorders of lipid metabolism, metabolic syndrome and familial combined hyperlipidemia]
A Steinmetz, J R Schäfer
Der Internist
|
May 13, 2020
[Current aspects and possibilities to improve patient safety]
J R Schäfer, H Haller
Der Internist
|
July 25, 2018
[Genetics in medicine]
H Haller, G Hasenfuß, J R Schäfer
Der Internist
|
April 2, 2017
[Computer-assisted diagnosis of rare diseases]
T Müller, A Jerrentrup, J R Schäfer
Zeitschrift Fur Kardiologie
|
November 25, 1998
[Lipid lowering therapy for primary prevention of coronary heart disease--pro lipid lowering therapy]
A Steinmetz, B Noll, B Maisch, et al.
Herz
|
September 19, 2000
[Cost effectiveness of pravastatin in secondary coronary prevention in patients with myocardial infarct or unstable angina in Germany. An analysis on the basis of the LIPID trial]
T D Szucs, K Berger, W März, et al.
Clinical Chemistry
|
September 1, 1994
Quantification of apolipoprotein A-IV in human plasma by immunonephelometry
S Schwarz, B Haas, C Luley, et al.
Herz
|
October 3, 1998
[Pharmacoeconomic evaluation of pravastatin in the secondary prevention of coronary heart disease in patients with average cholesterol levels. An analysis for Germany based on the CARE study]
T D Szucs, G Guggenberger, K Berger, et al.
Virology
|
June 1, 1993
Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir
J R Schäfer, Y Kawaoka, W J Bean, et al.
Journal of Lipid Research
|
January 1, 1994
Rapid determination of apolipoprotein E phenotypes from whole plasma by automated isoelectric focusing using PhastSystem and immunofixation
R Hackler, J R Schäfer, S Motzny, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Wiener Medizinische Wochenschrift (1946)
|
January 1, 1994
[Secondary disorders of lipid metabolism, metabolic syndrome and familial combined hyperlipidemia]
A Steinmetz, J R Schäfer
Der Internist
|
May 13, 2020
[Current aspects and possibilities to improve patient safety]
J R Schäfer, H Haller
Der Internist
|
July 25, 2018
[Genetics in medicine]
H Haller, G Hasenfuß, J R Schäfer
Der Internist
|
April 2, 2017
[Computer-assisted diagnosis of rare diseases]
T Müller, A Jerrentrup, J R Schäfer
Zeitschrift Fur Kardiologie
|
November 25, 1998
[Lipid lowering therapy for primary prevention of coronary heart disease--pro lipid lowering therapy]
A Steinmetz, B Noll, B Maisch, et al.
Herz
|
September 19, 2000
[Cost effectiveness of pravastatin in secondary coronary prevention in patients with myocardial infarct or unstable angina in Germany. An analysis on the basis of the LIPID trial]
T D Szucs, K Berger, W März, et al.
Clinical Chemistry
|
September 1, 1994
Quantification of apolipoprotein A-IV in human plasma by immunonephelometry
S Schwarz, B Haas, C Luley, et al.
Herz
|
October 3, 1998
[Pharmacoeconomic evaluation of pravastatin in the secondary prevention of coronary heart disease in patients with average cholesterol levels. An analysis for Germany based on the CARE study]
T D Szucs, G Guggenberger, K Berger, et al.
Virology
|
June 1, 1993
Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir
J R Schäfer, Y Kawaoka, W J Bean, et al.
Journal of Lipid Research
|
January 1, 1994
Rapid determination of apolipoprotein E phenotypes from whole plasma by automated isoelectric focusing using PhastSystem and immunofixation
R Hackler, J R Schäfer, S Motzny, et al.
Page
of 2